New indazole derivatives as phosphodiesterase type 4 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 605-608

Informa Healthcare

Access to resources Recommend Favorite

Optimizing the Use of Tumour Necrosis Factor Inhibitors in Crohn's Disease: A Practical Approach

By >   Ordás Ingrid   Ricart Elena  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 109-120

Adis International

Access to resources Recommend Favorite

Nicotinamide derivatives as selective inhibitors of PDE4

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 481-485

Informa Healthcare

Access to resources Recommend Favorite

New anti-inflammatory N-pyridinyl(alkyl)phthalimides acting as tumour necrosis factor- production inhibitors

By Collin X.   Robert J.-M.   Wielgosz G.   Le Baut G.   Bobin-Dubigeon C.   Grimaud N.   Petit J.-Y.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 7, 2001-08 ,pp. : 639-649

Elsevier

Access to resources Recommend Favorite

In Vitro Cytotoxicity Evaluation of Some Substituted Indazole Derivatives

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 7, 2007-01 ,pp. : 467-470

Bentham Science Publishers

Access to resources Recommend Favorite